Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30086172HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30084988HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30055183HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30055184HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30055185HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30055186HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS30055187HIVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS20038778HPVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS20023449HPVENSG00000186716.21protein_codingBCRYesNo613P11274
TVIS44030081HTLV-1ENSG00000186716.21protein_codingBCRYesNo613P11274
TCGA Plot Options
Drug Information
GeneBCR
DrugBank IDDB00619
Drug NameImatinib
Target IDBE0004743
UniProt IDP11274
Regulation Typeinhibitor
PubMed IDs15206509; 20072827; 12600228; 23226582
CitationsNadal E, Olavarria E: Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies. Int J Clin Pract. 2004 May;58(5):511-6.@@Waller CF: Imatinib mesylate. Recent Results Cancer Res. 2010;184:3-20. doi: 10.1007/978-3-642-01222-8_1.@@Croom KF, Perry CM: Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. Drugs. 2003;63(5):513-22; discussion 523-4.@@Reddy EP, Aggarwal AK: The ins and outs of bcr-abl inhibition. Genes Cancer. 2012 May;3(5-6):447-54. doi: 10.1177/1947601912462126.
GroupsApproved
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
PathwaysImatinib Inhibition of BCR-ABL
PharmGKBPA10804
ChEMBLCHEMBL941